192 related articles for article (PubMed ID: 34519855)
1. Cell culture-based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system.
Hein MD; Chawla A; Cattaneo M; Kupke SY; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2021 Oct; 105(19):7251-7264. PubMed ID: 34519855
[TBL] [Abstract][Full Text] [Related]
2. Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles.
Hein MD; Arora P; Marichal-Gallardo P; Winkler M; Genzel Y; Pöhlmann S; Schughart K; Kupke SY; Reichl U
BMC Biol; 2021 May; 19(1):91. PubMed ID: 33941189
[TBL] [Abstract][Full Text] [Related]
3. Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.
Pelz L; Rüdiger D; Dogra T; Alnaji FG; Genzel Y; Brooke CB; Kupke SY; Reichl U
J Virol; 2021 Nov; 95(24):e0117421. PubMed ID: 34550771
[TBL] [Abstract][Full Text] [Related]
4. Production of antiviral "OP7 chimera" defective interfering particles free of infectious virus.
Pelz L; Dogra T; Marichal-Gallardo P; Hein MD; Hemissi G; Kupke SY; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2024 Dec; 108(1):97. PubMed ID: 38229300
[TBL] [Abstract][Full Text] [Related]
5. Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture.
Rüdiger D; Pelz L; Hein MD; Kupke SY; Reichl U
PLoS Comput Biol; 2021 Sep; 17(9):e1009357. PubMed ID: 34491996
[TBL] [Abstract][Full Text] [Related]
6. Cell culture-based production of defective interfering particles for influenza antiviral therapy.
Wasik MA; Eichwald L; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2018 Feb; 102(3):1167-1177. PubMed ID: 29204901
[TBL] [Abstract][Full Text] [Related]
7. Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times-Insights From qPCR Measurements and Viral Dynamics Modeling.
Tapia F; Laske T; Wasik MA; Rammhold M; Genzel Y; Reichl U
Front Bioeng Biotechnol; 2019; 7():275. PubMed ID: 31681751
[TBL] [Abstract][Full Text] [Related]
8. Performance of an acoustic settler versus a hollow fiber-based ATF technology for influenza virus production in perfusion.
Gränicher G; Coronel J; Trampler F; Jordan I; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4877-4888. PubMed ID: 32291490
[TBL] [Abstract][Full Text] [Related]
9. Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration.
Göbel S; Pelz L; Silva CAT; Brühlmann B; Hill C; Altomonte J; Kamen A; Reichl U; Genzel Y
Appl Microbiol Biotechnol; 2024 Feb; 108(1):240. PubMed ID: 38413399
[TBL] [Abstract][Full Text] [Related]
10. High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.
Genzel Y; Vogel T; Buck J; Behrendt I; Ramirez DV; Schiedner G; Jordan I; Reichl U
Vaccine; 2014 May; 32(24):2770-81. PubMed ID: 24583003
[TBL] [Abstract][Full Text] [Related]
11. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.
Kupke SY; Riedel D; Frensing T; Zmora P; Reichl U
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463972
[TBL] [Abstract][Full Text] [Related]
12. Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
Coronel J; Behrendt I; Bürgin T; Anderlei T; Sandig V; Reichl U; Genzel Y
Vaccine; 2019 Nov; 37(47):7011-7018. PubMed ID: 31266669
[TBL] [Abstract][Full Text] [Related]
13. Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.
Tapia F; Vázquez-Ramírez D; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2016 Mar; 100(5):2121-32. PubMed ID: 26758296
[TBL] [Abstract][Full Text] [Related]
14. Generation of "OP7 chimera" defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice.
Dogra T; Pelz L; Boehme JD; Kuechler J; Kershaw O; Marichal-Gallardo P; Baelkner M; Hein MD; Gruber AD; Benndorf D; Genzel Y; Bruder D; Kupke SY; Reichl U
Sci Rep; 2023 Nov; 13(1):20936. PubMed ID: 38017026
[TBL] [Abstract][Full Text] [Related]
15. Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro.
Pelz L; Piagnani E; Marsall P; Wynserski N; Hein MD; Marichal-Gallardo P; Kupke SY; Reichl U
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766278
[TBL] [Abstract][Full Text] [Related]
16. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U
Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064
[TBL] [Abstract][Full Text] [Related]
17. Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review.
Wu M; Zhou E; Sheng R; Fu X; Li J; Jiang C; Su W
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560777
[TBL] [Abstract][Full Text] [Related]
18. Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.
Frensing T; Heldt FS; Pflugmacher A; Behrendt I; Jordan I; Flockerzi D; Genzel Y; Reichl U
PLoS One; 2013; 8(9):e72288. PubMed ID: 24039749
[TBL] [Abstract][Full Text] [Related]
19. Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity.
Bdeir N; Arora P; Gärtner S; Pöhlmann S; Winkler M
Sci Rep; 2021 Oct; 11(1):20477. PubMed ID: 34650149
[TBL] [Abstract][Full Text] [Related]
20. Modeling the intracellular replication of influenza A virus in the presence of defective interfering RNAs.
Laske T; Heldt FS; Hoffmann H; Frensing T; Reichl U
Virus Res; 2016 Feb; 213():90-99. PubMed ID: 26592173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
